Skip to main content

Elevidys Disease Interactions

There is 1 disease interaction with Elevidys (delandistrogene moxeparvovec).

Moderate

Delandistrogene moxeparvovec (applies to Elevidys) hepatic impairment

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease

Administration of delandistrogene moxeparvovec in patients with hepatic impairment, acute liver disease, chronic hepatic conditions, or elevated GGT has not been studied. Treatment with this drug should be carefully considered in patients with preexisting-existing hepatic impairment or chronic hepatic viral infection as this population may be at increased risk of acute serious liver injury. Postpone administration of delandistrogene moxeparvovec in patients with acute liver disease until it is resolved or controlled. Elevated liver function tests are commonly reported in patients after treatment with this drug. Assess liver enzymes prior to treatment, and then monitor liver function weekly for 3 months after infusion, or until results are unremarkable.

References

  1. (2023) "Product Information. Elevidys (10-10.4 kg) (delandistrogene moxeparvovec)." Sarepta Therapeutics

Elevidys drug interactions

There are 31 drug interactions with Elevidys (delandistrogene moxeparvovec).


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.